Trials / Sponsors / Ranok Therapeutics (Hangzhou) Co., Ltd.
Ranok Therapeutics (Hangzhou) Co., Ltd.
Industry · 4 registered clinical trials — 4 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Study to Evaluate the Food Effect on RNK08954 in Healthy Participants, and the Mass Balance Study of [14C]RN Food Effect, Mass Balance | Phase 1 | 2025-12-31 |
| Recruiting | To Evaluate the Safety and Efficacy of RNK08954 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma. KRAS G12D Mutations, Pancreatic Ductal Adenocarcinoma (PDAC) | Phase 2 | 2025-10-14 |
| Recruiting | A Study of RNK08954 in Subjects With Advanced Solid Tumors With KRAS ((Kirsten Rat Sarcoma) G12D Mutation KRAS G12D Mutation | Phase 1 / Phase 2 | 2024-11-08 |
| Recruiting | A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1) Advanced Solid Tumor, DLBCL | Phase 1 / Phase 2 | 2022-07-12 |